Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
481 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06394570 | Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer(STAR-EV) | recruiting | Phase 1 / Phase 2 | 19 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 30, 2026 | clinicaltrials |
| NCT06977711 | Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL) | recruiting | Phase 1 | 10 | The University of Texas Health Science Center at San AntonioOTHER |
| 1 |
| Sep 29, 2026 |
| clinicaltrials |
| NCT07100847 | Periprostatic Neurolysis in Prostate Cancer | active not recruiting | Phase 1 | 21 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT06084234 | National Liver Cancer Screening Trial(TRACER) | recruiting | Phase 4 | 5,500 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT04040569 | A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer | active not recruiting | Phase 1 | 45 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT07158892 | Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test | not yet recruiting | N/A | 220 | University of Texas at AustinOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT07470606 | Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain(MemoryRT) | recruiting | Phase 2 | 108 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT03508752 | Neurocognitive Decline in Patients With Brain Metastases | active not recruiting | Phase 1 / Phase 2 | 80 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05021237 | Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer | completed | Phase 2 | 12 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05319015 | Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus | recruiting | Phase 2 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05672927 | Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | recruiting | Phase 4 | 618 | The University of Texas Medical Branch, GalvestonOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07770646 | A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis | not yet recruiting | Phase 4 | 40 | The University of Texas Health Science Center, HoustonOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT07446257 | THIO and Cadonilimab in Resectable Hepatocellular Carcinoma | recruiting | Early Phase 1 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT05402033 | Cancer Clinical Trials Financial Reimbursement Program | recruiting | — | 1,200 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07700420 | Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer | recruiting | Phase 1 | 15 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT02956798 | SAbR For Oligometastatic Renal Cell Carcinoma | completed | N/A | 23 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT02685332 | Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA | active not recruiting | Phase 1 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT05937269 | Assessing Impact of Early Physiotherapy on Lymphatic Dysfunction in Head and Neck Cancer Survivorship | active not recruiting | Phase 1 | 14 | The University of Texas Health Science Center, HoustonOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07254650 | Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1(CALMS-1) | not yet recruiting | N/A | 300 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07786428 | Tailored Neoadjuvant Chemoimmunotherapy for Stage I TNBC(DETENTE-1) | not yet recruiting | Phase 2 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT05120869 | Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention | completed | N/A | 161 | University of Texas, El PasoOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT07689175 | Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma | recruiting | Phase 2 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT05825950 | Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC) | recruiting | — | 600 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT07674771 | Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery(RIPCORD) | not yet recruiting | Early Phase 1 | 30 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT06098690 | Culturally Tailored HPV Psychoeducational Multimedia Intervention | completed | N/A | 63 | University of Texas, El PasoOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT05145816 | Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis | recruiting | Phase 1 / Phase 2 | 37 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT04865939 | Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma | recruiting | Phase 3 | 132 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT06574152 | Effect of Photobiomodulation on Pain and Healing of the Vertical Releasing Incision After Endodontic Microsurgery | recruiting | N/A | 90 | The University of Texas Health Science Center, HoustonOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07139990 | Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)(PRISM) | recruiting | Phase 1 | 105 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07751185 | Support and Healing Intervention for Adolescents With a Parent Diagnosed With Cancer (SHINE)(SHINE) | not yet recruiting | N/A | 80 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT05294991 | Wellness App for Sleep Disturbance in Hematological Cancer Patients(Heme) | active not recruiting | N/A | 276 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06076538 | PET/MR for Characterization of Renal Masses (RMs) | recruiting | — | 97 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT07550192 | Oncology Acute Care Follow-up Intervention Study | not yet recruiting | N/A | 200 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT07737171 | Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions | recruiting | — | 60 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT04990609 | EUS-RFA PANCARDINAL-1 Trial | recruiting | Phase 2 | 60 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT04677413 | Ultra-fractionated Radiotherapy for Rectal Cancer | active not recruiting | Phase 1 | 27 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT06883838 | Project CASCADE: Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement(CASCADE) | enrolling by invitation | N/A | 5,584 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT03546686 | Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer | active not recruiting | Phase 2 | 51 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT00992303 | Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants | recruiting | — | 10,000 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT07706127 | mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health | recruiting | N/A | 159 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT03705897 | PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings | completed | N/A | 9,264 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT05989893 | Mapping of Human Cognition | recruiting | N/A | 75 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT03747120 | Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP] | active not recruiting | Phase 2 | 138 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06444269 | Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial | recruiting | Phase 2 | 53 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06030011 | Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations | recruiting | N/A | 270 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT05724563 | Domvanalimab and Zimberelimab in Advanced Liver Cancers | active not recruiting | Phase 2 | 58 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT06184152 | CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules | recruiting | N/A | 600 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07680088 | Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer | not yet recruiting | Phase 2 | 17 | University of Texas Southwestern Medical CenterOTHER | 0 | Jul 2, 2026 | clinicaltrials |
| NCT02891538 | Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients | completed | Early Phase 1 | 51 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07313241 | Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)((RANGER)) | recruiting | Phase 2 | 68 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 30, 2026 | clinicaltrials |
Data updated 13 hours agoSource updated unknownsource: clinicaltrials